Bay Area
September 28, 2023: Implications of the IRA
April 25, 2023: Development & Manufacturing Challenges of Cell & Gene Therapies
Barbra Sasu, CSO, Allogene
David Schaffer, Director, Bakar BioEnginuity Hub & Bakar Labs
Faraz Siddiqui, SVP, Manufacturing Operations, IGM Biosciences
Julien Meissonnier, CSO, Catalent Pharma Solutions
Nicole Paulk, Assistant Professor, UCSF
Moderated by Chris Mason, Co-founder & former CSO, AVROBIO
September 8, 2022: Current & Future State of M&A
Darcy Mootz, Head, Amunix Pharmaceuticals
Jay Stamatis, VP & Head of BD & Acquisitions, AbbVie
Julianne Averill, CFO consultant, Danforth Advisors
Lori Hu, Managing Director, Vertex Ventures HC
Moderated by Samina Bari, Strategic Business Advisor, Cayuga Biotech
May 24, 2022: Status of the Industry
Anne Longmire, VP, JP Morgan
Brent Vaughan, CEO, Cognito Therapeutics
Mike Guerra, CEO, CA Life Sciences
Shelley Chu, Partner, Lightspeed Venture Partners
Moderated by Ben Conway, consultant, Danforth Advisors